University of California San Francisco
Give to UCSFA man was paralyzed from the neck down in a surfing accident. Now he can walk again. Using machine learning, UCSF researchers found that controlling blood pressure during surgery may aid in patient recovery from spinal cord injuries.
A UCSF and Stanford study of electronic health records linked SSRIs, the most widely prescribed antidepressants, to survival for COVID-19 patients.
UCSF researchers have discovered a new type of cell that may be responsible for the exaggerated immune response behind inflammatory disease.
The new Weill Neurosciences Building, designed to foster connections among scientists and clinicians in neurology, neurosurgery and psychiatry, will serve as a global destination for researchers to develop innovative treatments for intractable brain diseases.
UCSF’s research has been ranked among the top in the world, according to the latest U.S. News & World Report’s Best Global Universities 2022 rankings.
Three adolescents who had mild or asymptomatic COVID-19 developed sudden severe psychiatric symptoms. A recent study into their immune responses identifies a potential mechanism by which these symptoms emerge.
The University of California, Berkeley and the UCSF have jointly launched a new, one-of-a-kind program in computational precision health, a significant step toward advancing this new field and, ultimately, improving the quality and equity of health care.
A groundbreaking national study led by UCSF finds that treating anal cancer precursor lesions reduces cancer risk for people with HIV.
Two new studies of the developing human brain are helping researchers reconcile a long-held debate over how the brain forms.
UCSF Health physicians have successfully treated a patient with severe depression by tapping into the specific brain circuit involved in depressive brain patterns and resetting them using the equivalent of a pacemaker for the brain.
A new prostate cancer test developed by UCSF and UCLA detects cancer cells that have spread to lymph nodes both inside and outside the pelvis.
Glioblastoma is the most common malignant brain tumor and among the most treatment-resistant cancers. In the last 15 years, numerous attempts to develop new drugs for glioblastoma have failed.
Trauma leaves marks on the body, as well as the mind. UCSF scientists have identified an immune signature to indicate which patients will respond best to therapy.
A clinical trial of new treatment regimens, led in part by researchers at UCSF, recently demonstrated that a more potent combination of antibiotics could shorten the duration of treatment for TB.
Most patients on immunosuppressive drugs for chronic inflammatory conditions, like rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease, can still produce antibodies after receiving the mRNA COVID-19 vaccines, researchers at UCSF and Washington University have concluded.
A single glass of wine can quickly raise the drinker’s risk for atrial fibrillation, according to new research by UCSF.
In a new study, an artificial intelligence algorithm exceeded the performance of a widely available commercial system in nearly all examined diagnoses.
A team of researchers at UCSF have recently sequenced the condor genome, shining light on the species’ history and opening the door to a better understanding of genomics in small populations, for the benefit of both condors and humans.
We spoke to UCSF virologist Nadia Roan, PhD, about the latest developments in our knowledge of the Delta variant, including how the new variant spreads so efficiently, whether it causes more serious illness, and why she thinks vaccines will hold the line.
UCSF researchers have leveraged two new molecules, one of which is currently in clinical oncology trials, to devise a dual-drug therapy for alcohol use disorder (AUD), without the side effects or complications associated with current treatment regimens.